Precision Trials

Precision Trials™ is ConcertAI's SaaS solution designed to bring speed, precision, and confidence to clinical development. By combining real-world data (RWD) with agentic and generative AI, Precision Trials enables pharmaceutical and biotech organizations to rapidly optimize clinical trial strategies — covering precise site selection, streamlined protocol development, and accurate patient recruitment forecasting. The platform is purpose-built for oncology, leveraging near real-time RWD to ensure trial designs reflect actual clinical practice.

Precision Trials is built for two primary user groups: Clinical Development teams responsible for eligibility criteria selection, study design, and alignment with scientific and regulatory requirements; and Clinical Operations teams who manage the end-to-end execution of clinical trials from start-up through close-out. Together, these teams use Precision Trials to reduce screen failures, minimize unplanned amendments, and accelerate enrollment timelines.

Core AI-Powered Capabilities

• Cohort Builder Agent: Reads inclusion and exclusion criteria in natural language form, using AI agents to generate patient cohorts in minutes based on near real-time oncology RWD.
• Cohort Exploration Agent: Enables in-depth analysis of disease prevalence and patient population characteristics through a natural language interface, allowing teams to define and refine ideal patient populations quickly.
• Site Selection Agent: Builds study enrollment models based on site recommendations, identifying high-performing sites and reducing reliance on non-productive ones.
• Study Design Agent: Performs standard-of-care to study design alignment analysis, ensuring that protocol criteria reflect real-world clinical practice and reducing the risk of costly amendments.

Measurable Value and Impact

• Reduce substantial study amendments in Phase II and Phase III studies by up to 50%, eliminating three or more months of amendment-related delays per study.
• Decrease unexpected budget overruns associated with unplanned protocol changes.
• Reduce non-productive sites by 25%, lowering per-patient costs by more than 10% through more effective site spend allocation.
• Shorten overall study timelines by selecting better-performing sites, reducing the number of sites and the duration required to complete a trial.
• Accelerate time to commercial launch by 3 to 9 months, pulling revenue forward and getting therapies to patients faster.

Key Workflow Benefits

• Define and refine ideal patient populations and inclusion/exclusion criteria using AI agents in minutes rather than weeks.
• Conduct in-depth cohort analysis via a natural language interface without requiring specialized data science skills.
• Ensure protocols reflect actual clinical practice to reduce screen failures and accelerate patient enrollment.
• Model trial feasibility and optimize protocols before study initiation to avoid costly mid-study corrections.
• Select high-performing investigator sites based on real-world enrollment data and predictive modeling.

Precision Trials is part of ConcertAI's broader Precision Suite of oncology-focused solutions. It is delivered as a SaaS platform, making it accessible to Clinical Development and Clinical Operations teams throughout the trial lifecycle — from initial evidence planning and protocol design through site selection, enrollment optimization, and study execution.